Clinical trial

Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes

NCT06911060

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Flaxseed Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Diet Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-01

PhaseNA

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Interventions

FlaxseedDIETARY_SUPPLEMENT

DietBEHAVIORAL

Sponsors & collaborators

Ondokuz Mayıs Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06911060 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.